Cart
sales@molnova.com
NP3-146
CAS No. 210826-47-4
NP3-146( —— )
Catalog No. M35127 CAS No. 210826-47-4
NP3-146 (NLRP3-IN-5) is an inflammasome NLRP3 inhibitor with potential anti-inflammatory activity for the study of autoimmune diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 922 | In Stock |
|
| 10MG | 1226 | In Stock |
|
| 25MG | 1853 | In Stock |
|
| 50MG | 2437 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNP3-146
-
NoteResearch use only, not for human use.
-
Brief DescriptionNP3-146 (NLRP3-IN-5) is an inflammasome NLRP3 inhibitor with potential anti-inflammatory activity for the study of autoimmune diseases.
-
DescriptionNP3-146 (NLRP3-IN-5) is an inflammasome NLRP3 inhibitor with potential anti-inflammatory activity for the study of autoimmune diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNF-κB
-
TargetNOD
-
RecptorNOD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number210826-47-4
-
Formula Weight442.96
-
Molecular FormulaC20H27ClN2O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC=1C(=CC(Cl)=CC1C(C)C)C(C)C)NS(=O)(=O)C=2OC=C(C2)C(O)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NT-0249
NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.
-
ADS032
ADS032 (BT-032) is an NLRP1 and NLRP3 inhibitor with anti-inflammatory activity,, inhibits the activation of NLRP1 and NLRP3, inhibits Nigericin-induced IL-1β production, and can be used to study respiratory inflammation or infection.
-
NLRP3-IN-11
NLRP3-IN-11 is an NLRP3 protein inhibitor with potential anti-inflammatory activity.NLRP3-IN-11 can be used in the study of atherosclerosis and parkinsonism.
